Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment – POLITICO
But for the U.S. pharmaceutical company — which shelved its planned facility meant to support early-stage life sciences…
US trade envoy Jamieson Greer to visit London in late November – POLITICO
Ministers agreed last week to a two-week extension to the deadline by which pharma firms must tell the…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
Britain prepares NHS drug spending hike to stave off Trump tariffs – POLITICO
A U.K. government spokesperson said: “The pharmaceutical sector and the innovative medicines it produces are critical to our…
Trump tariff threats punch holes in UK trade deal – POLITICO
Britain’s auto industry also only exports a small amount of Heavy Goods Vehicles to the U.S., but “we’re…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
US drug pricing shake-up threatens access to medicines in Europe – POLITICO
For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on…